US Broker Ratings

Genmab A/S (GMAB) Stock Analysis: Strong Buy Ratings and Nearly 30% Potential Upside

Genmab A/S (GMAB) is attracting significant attention in the biotech sector, with a compelling blend of innovative therapies and promising financial indicators. Based in Denmark, this biotechnology powerhouse has carved..

Bristol-Myers Squibb (BMY) Stock Analysis: What Investors Need to Know About Its 4.19% Dividend Yield and Growth Potential

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, is a key player in the drug manufacturing industry, with a market capitalization of $122.85 billion. The company’s extensive..

Abbott Laboratories (ABT) Stock Analysis: Evaluating Growth Potential with a 23.95% Upside

Abbott Laboratories (NYSE: ABT), a prominent player in the healthcare sector, particularly in the medical devices industry, is capturing investor attention with its promising growth prospects. With a market capitalization..

Danaher Corporation (DHR) Stock Analysis: 31% Upside Potential with Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector specializing in diagnostics and research, stands out as a compelling investment opportunity. With a market capitalization of $137.82 billion,..

Mettler-Toledo International (MTD) Stock Analysis: Assessing a 11% Potential Upside in the Healthcare Sector

Mettler-Toledo International Inc. (NYSE: MTD), a heavyweight in the diagnostics and research industry, stands out as a compelling investment opportunity within the healthcare sector. Headquartered in Greifensee, Switzerland, this company..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 31.85% Potential Upside for Investors

For investors eyeing the healthcare sector, Agilent Technologies, Inc. (NYSE: A) presents an intriguing opportunity with a projected potential upside of 31.85%. This diagnostics and research powerhouse, headquartered in Santa..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Powerhouse with 24% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, with a current market capitalization of $112.22 billion. Known for its transformative medicines targeting serious diseases,..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Insights into a Leading Indian Pharmaceutical Player with a 7.58% Potential Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a key player in the global pharmaceutical industry, offers a compelling investment opportunity for those looking to diversify their portfolios within the healthcare sector...

Cencora, Inc. (COR) Stock Analysis: Evaluating a 23% Potential Upside in the Healthcare Distribution Sector

Investors with an eye on the healthcare distribution industry should take note of Cencora, Inc. (NYSE: COR), a leading player with a market capitalization of $63.72 billion. Formerly known as..

Insulet Corporation (PODD) Stock Analysis: A 63.6% Potential Upside Sparks Investor Interest

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector specializing in medical devices, particularly insulin delivery systems, is currently making waves in the investment community. With a market..

Sanofi (SNY) Stock Analysis: Strong Dividend Yield and Potential Upside Attract Investor Attention

Sanofi (SNY), a dominant player in the healthcare sector, is renowned for its diverse portfolio of therapeutic solutions, including immunology, oncology, and rare diseases. Based in France, Sanofi commands a..

Becton, Dickinson and Company (BDX) Stock Analysis: A Look at Its 20.77% Potential Upside

For investors seeking stability in the healthcare sector, Becton, Dickinson and Company (NYSE: BDX) presents a compelling opportunity. With a market capitalization of $57.44 billion, Becton, Dickinson is a major..

Baxter International Inc. (BAX) Stock Analysis: Exploring an 18.20% Potential Upside Amidst Healthcare Growth

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, operates in the medical instruments and supplies industry with a market capitalization of $9.66 billion. With a rich..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unlocking a 62.65% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a stalwart in the biotechnology sector, continues to capture the attention of investors with its promising pipeline and strong market presence in treatment for rare..

United Therapeutics Corporation (UTHR) Stock Analysis: A Robust Healthcare Play with a 9.47% Upside

United Therapeutics Corporation (NASDAQ: UTHR) presents a compelling opportunity for investors seeking exposure to the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market..

Edwards Lifesciences Corporation (EW) Stock Analysis: A High-Stakes Bet in Medical Devices with 18.94% Upside

Investors with an eye on the healthcare sector may find Edwards Lifesciences Corporation (NYSE: EW) an intriguing opportunity, thanks to its innovative edge in the medical devices industry and a..

Universal Health Services, Inc. (UHS) Stock Analysis: A Potential 35.60% Upside in Healthcare Investment

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, offers an intriguing investment opportunity with a potential upside of 35.60%. With a market capitalization of $11.14..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A 45% Potential Upside Amidst Robust Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading player in the biotechnology sector, has captured investor attention with its cutting-edge therapeutics based on ribonucleic acid interference (RNAi). With a market capitalization..

Natera, Inc. (NTRA) Stock Analysis: A 23.78% Potential Upside Amid Robust Revenue Growth

Natera, Inc. (NASDAQ: NTRA) is capturing the attention of investors with its strong footing in the healthcare sector, specifically within the diagnostics and research industry. As a leader in molecular..

GE HealthCare Technologies Inc. (GEHC): Investor Outlook on a Medical Device Giant with a 21.53% Potential Upside

For investors seeking opportunities in the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents a compelling prospect. The company, which operates in the medical devices industry, has established itself..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds